Your browser doesn't support javascript.
loading
The dose of cyclophosphamide for treating paraquat-induced rat lung injury
The Korean Journal of Internal Medicine ; : 420-427, 2013.
Artigo em Inglês | WPRIM | ID: wpr-212582
ABSTRACT
BACKGROUND/

AIMS:

Cyclophosphamide (CP) is a promising treatment for severe cases of paraquat (PQ) poisoning. We investigated the effective dose of CP for mitigating PQ-induced lung injury.

METHODS:

Adult male Sprague-Dawley rats were allocated into five groups control, PQ (35 mg/kg, intraperitoneal injection), and PQ + CP (1.5, 15, or 30 mg/kg). The dimensions of lung lesions were determined using X-ray microtomography (micro-CT), and histological changes and cytokine levels were recorded.

RESULTS:

The micro-CT results showed that 15 mg/kg CP was more effective than 1.5 mg/kg CP for treating PQ-induced lung injury. At a dose of 1.5 mg/kg, CP alleviated the histological evidence of inflammation and altered superoxide dismutase activity. Using 15 mg/kg CP reduced the elevated catalase activity and serum transforming growth factor (TGF)-beta1 level.

CONCLUSIONS:

A CP dose of > 15 mg/kg is effective for reducing the severity of PQ-induced lung injury as determined by histological and micro-CT tissue examination, possibly by modulating antioxidant enzyme and TGF-beta1 levels.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Paraquat / Edema Pulmonar / Superóxido Dismutase / Índice de Gravidade de Doença / Catalase / Citocinas / Ratos Sprague-Dawley / Estresse Oxidativo / Mediadores da Inflamação / Ciclofosfamida Tipo de estudo: Estudo prognóstico Limite: Animais Idioma: Inglês Revista: The Korean Journal of Internal Medicine Ano de publicação: 2013 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Paraquat / Edema Pulmonar / Superóxido Dismutase / Índice de Gravidade de Doença / Catalase / Citocinas / Ratos Sprague-Dawley / Estresse Oxidativo / Mediadores da Inflamação / Ciclofosfamida Tipo de estudo: Estudo prognóstico Limite: Animais Idioma: Inglês Revista: The Korean Journal of Internal Medicine Ano de publicação: 2013 Tipo de documento: Artigo